(NaturalNews) Industry-funded investigators and researchers that are also on the payroll of the National Institutes of Health (NIH) often go unnoticed because no rule exists requiring them to make such information public. But in an effort to increase transparency, honesty, and full disclosure within the medical community, the Project on Government Oversight (POGO) is urging the NIH to include public disclosure requirements in its Final Rule on the issue.
NaturalNews covered POGO's efforts back in March to get the attention of NIH Director Francis Collins concerning the fact that its researchers were secretly on drug company payrolls. Collins agreed with POGO's proposal that such industry connections need to be disclosed publicly, but nothing much has happened since that time to address the problem.
In a more recent letter to Collins, POGO is again urging Collins and the NIH to require that medical researchers' connections with the drug industry be publicly disclosed on searchable databases that can be easily accessed by the public. The group is also requesting that if medical researchers lie about such connections, that they be prosecuted to the full extent of the law.
Since Collins has already verbally expressed support for the proposal -- and even submitted comments to the New England Journal of Medicine that helped further spark public interest in the idea -- it is now only a matter of prodding him and the agency to actually make it happen.
You can express support for requiring full, public disclosure of NIH medical researchers' industry connections by writing to: Francis S. Collins, MD, PhD Director National Institutes of Health Bethesda, Maryland 20892
You can also email Collins directly at: Francis.Collins@nih.hhs.gov